Kusum Healthcare Private Limited — Leflunomide Exporter Profile
Indian Pharmaceutical Exporter · #3 for Leflunomide · $1.3M export value · DGFT Verified
Kusum Healthcare Private Limited is the #3 Indian exporter of Leflunomide with $1.3M in export value and 56 verified shipments. Kusum Healthcare Private Limited holds a 9.0% market share in Leflunomide exports across 9 countries. The company exports 13 pharmaceutical products worth $21.0M across 7 therapeutic categories.
Kusum Healthcare Private Limited — Leflunomide Export Profile: Buyers & Destinations
Where Does Kusum Healthcare Private Limited Export Leflunomide?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UKRAINE | $330.6K | 14 | 26.6% |
| UZBEKISTAN | $290.4K | 7 | 23.4% |
| KAZAKISTAN | $200.2K | 7 | 16.1% |
| MYANMAR | $173.3K | 10 | 14.0% |
| KAZAKHSTAN | $118.8K | 4 | 9.6% |
| THAILAND | $98.7K | 5 | 7.9% |
| PHILIPPINES | $13.1K | 2 | 1.1% |
| TANZANIA | $10.1K | 3 | 0.8% |
| CAMBODIA | $6.0K | 3 | 0.5% |
| MOLDOVA,REPUBLIC OF | $622 | 1 | 0.1% |
Kusum Healthcare Private Limited exports Leflunomide to 10 countries. The largest destination is UKRAINE accounting for 26.6% of Kusum Healthcare Private Limited's Leflunomide shipments, followed by UZBEKISTAN (23.4%) and KAZAKISTAN (16.1%). These destinations reflect Kusum Healthcare Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Leflunomide from Kusum Healthcare Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| LLP "DARI-PHARM (KAZAKHSTAN) | KAZAKISTAN | $269.0K | 10 |
| GLADPHARM LTD. | UKRAINE | $225.5K | 9 |
| FE BARAKA DORI FARM, LLC | UZBEKISTAN | $113.3K | 3 |
| FE BARAKA DORI FARM LLC | UZBEKISTAN | $100.0K | 2 |
| ATLANTA MEDICARE CO., LTD. | THAILAND | $98.7K | 5 |
| J.D.S CO., LTD. | MYANMAR | $77.9K | 5 |
| FE BARAKA DORI FARM, LLC. | UZBEKISTAN | $77.1K | 2 |
| GLADPHARM LTD | UKRAINE | $60.9K | 3 |
| LLP DARI-PHARM KAZAKHSTAN | KAZAKHSTAN | $50.0K | 1 |
| NO.9, YAWMINGYI LANE, | MYANMAR | $50.0K | 1 |
Kusum Healthcare Private Limited supplies Leflunomide to 19 buyers globally. The largest buyer is LLP "DARI-PHARM (KAZAKHSTAN) (KAZAKISTAN), followed by GLADPHARM LTD. (UKRAINE) and FE BARAKA DORI FARM, LLC (UZBEKISTAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Leflunomide Export Value and How Much Does Kusum Healthcare Private Limited Contribute?
India exported $12.8M worth of Leflunomide through 816 shipments from 106 suppliers to 63 countries, serving 202 buyers globally. Kusum Healthcare Private Limited contributes $1.3M to this total, accounting for 9.0% of India's Leflunomide exports. Kusum Healthcare Private Limited ships Leflunomide to 10 countries through 19 buyers.
What Is the Average Shipment Value for Kusum Healthcare Private Limited's Leflunomide Exports?
Kusum Healthcare Private Limited's average Leflunomide shipment value is $24.0K per consignment, based on 56 shipments totaling $1.3M. The largest destination is UKRAINE (26.6% of Kusum Healthcare Private Limited's Leflunomide exports).
How Does Kusum Healthcare Private Limited Compare to Other Indian Leflunomide Exporters?
Kusum Healthcare Private Limited ranks #3 among 106 Indian Leflunomide exporters with a 9.0% market share. The top 3 exporters are ZYDUS LIFESCIENCES LIMITED ($3.8M), TORRENT PHARMACEUTICALS LTD ($2.3M), KUSUM HEALTHCARE PRIVATE LIMITED ($1.3M). Kusum Healthcare Private Limited processed 56 shipments to 9 destination countries.
What Leflunomide Formulations Does Kusum Healthcare Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| LEFNO-20 TABLETS 3X10S (LEFLUNOMIDE 20M | $271.6K | 13 |
| LEFNO-20 TABLETS 3X10S(LEFLUNOMIDE 20MG | $260.7K | 7 |
| LEFNO-20 TABLETS 3X10S LEFLUNOMIDE 20M | $100.0K | 2 |
| LEFNO-20 TABLETS 3X10S(LEFLUNOMIDE 20MGTABLETS)BNO1003215,DOM01.2024,DOE12.2026 | $78.3K | 2 |
| LEFNO-20 TABLETS 3X10S LEFLUNOMIDE 20MG B.NO.1001832 DOM- 04.2023 DOE-03.2026/B.NO.1001833 DOM-05.2023 DOE-04.2026 | $50.0K | 1 |
| LEFNO-20 TABLETS 3X10S (LEFLUNOMIDE 20MG TABLETS) BT NO. 1002327 DOM-09.2023 DOE-08.2026 | $50.0K | 1 |
| LEFNO-20 TABLETS 3X10S (LEFLUNOMIDE 20MG TABLETS) BATCH NO 2006522,2006524 D.O.M 09.2022 D.O.E 08.2025 | $50.0K | 1 |
| LEFNO TABLETS 3X10S (LEFLUNOMIDE 20MG TABLETS)B.NO:1005666,1005667,DOM.01/2025,DOE.12/2027 | $50.0K | 1 |
| LEFNO-20 TABLETS 3X10SLEFLUNOMIDE 20MGTABLETSBNO.1002452DOM09.2023DOE08.2026 | $43.7K | 1 |
| LEFNO 20 TABLETS 3X10S LEFLUNOMIDE 20MG TABLETS B N 1006533 DOM 03 2025 DOE 02 2028 | $41.6K | 1 |
Kusum Healthcare Private Limited exports 33 distinct Leflunomide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is LEFNO-20 TABLETS 3X10S (LEFLUNOMIDE 20M with 13 shipments worth $271.6K.
How Does Kusum Healthcare Private Limited Compare to Nearest Leflunomide Exporters?
Exporters ranked immediately above and below #3 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | ZYDUS LIFESCIENCES LIMITED | $3.8M | 75 | 1 | $50.0K |
| 2 | TORRENT PHARMACEUTICALS LTD | $2.3M | 45 | 8 | $50.0K |
| 3 | KUSUM HEALTHCARE PRIVATE LIMITED ★ | $1.3M | 56 | 9 | $24.0K |
| 4 | EMCURE PHARMACEUTICALS LIMITED | $1.2M | 91 | 7 | $12.8K |
| 5 | ALEMBIC PHARMACEUTICALS LIMITED | $1.2M | 87 | 6 | $13.3K |
Kusum Healthcare Private Limited ranks #3 among 106 Indian Leflunomide exporters. Average shipment value of $24.0K compared to the market average of $120.8K. The closest competitors by value are ZYDUS LIFESCIENCES LIMITED and TORRENT PHARMACEUTICALS LTD.
Which Indian Ports Ship Leflunomide Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 126 | 15.4% |
| SAHAR AIR | 98 | 12.0% |
| SAHAR AIR CARGO ACC (INBOM4) | 88 | 10.8% |
| DELHI AIR | 79 | 9.7% |
| NHAVA SHEVA SEA (INNSA1) | 69 | 8.5% |
| MUNDRA SEA | 69 | 8.5% |
| Delhi Air | 28 | 3.4% |
| Bombay Air | 25 | 3.1% |
Geopolitical & Trade Policy Impact on Kusum Healthcare Private Limited's Leflunomide Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Kusum Healthcare. Escalating tensions in the Middle East, particularly the Israel-Iran conflict, have disrupted key shipping routes such as the Red Sea and the Strait of Hormuz. These disruptions have led to increased freight charges, with surcharges ranging from $4,000 to $8,000 per shipment, posing a potential loss of ₹2,500 to ₹5,000 crore for the Indian pharmaceutical industry. (businesstoday.in)
Conversely, the U.S. pharmaceutical import policies are undergoing significant changes. The Trump administration's imposition of broad tariffs on imports from over 60 countries, including India, with rates reaching up to 39%, has introduced uncertainties. While these tariffs aim to spur domestic investment, they also risk disrupting global trade and increasing consumer prices. (apnews.com) For Kusum Healthcare, this necessitates a strategic reassessment of its export strategies to the U.S. market.
In the European Union, the implementation of the Falsified Medicines Directive (FMD) requires stringent compliance measures. Indian exporters must adapt to these regulatory changes to maintain market access. Additionally, the India–EFTA Trade and Economic Partnership Agreement, effective from October 2025, aims to eliminate or reduce tariffs on goods traded between India and EFTA countries, potentially opening new avenues for Kusum Healthcare in European markets. (en.wikipedia.org)
Kusum Healthcare Private Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practices (EU GMP) set rigorous quality benchmarks. Any lapses can lead to import bans or recalls, adversely affecting market reputation and financial performance.
For Kusum Healthcare, maintaining adherence to these standards is crucial, especially in light of recent geopolitical tensions that have heightened scrutiny on supply chain integrity. Proactive engagement with regulatory bodies and continuous quality assurance measures will be essential to navigate this complex landscape.
About Kusum Healthcare Private Limited
Kusum Healthcare Private Limited exports 13 products worth $21.0M. Beyond Leflunomide, top products include Ketoconazole, Levofloxacin, Fluconazole, Clotrimazole, Biotin. View the complete Kusum Healthcare Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Leflunomide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Leflunomide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Kusum Healthcare Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 56 individual customs records matching Kusum Healthcare Private Limited exporting Leflunomide, covering 33 formulations to 10 countries via 19 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 63+ countries, 202+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Leflunomide Export Data from Kusum Healthcare Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Kusum Healthcare Private Limited's Leflunomide exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Kusum Healthcare Private Limited
Full Company Profile →
13 products · $21.0M total trade · 7 categories
Leflunomide Stats
Company Overview
Top Products by Kusum Healthcare Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Kusum Healthcare Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Leflunomide. For current shipment-level data, contact TransData Nexus.